Structures by: Kalluraya B.
Total: 164
4,5-Dichloro-2-methylpyridazin-3(2<i>H</i>)-one
C5H4Cl2N2O
Acta Crystallographica Section E (2009) 65, 12 o3055
a=6.51570(10)Å b=15.9127(4)Å c=13.5175(3)Å
α=90.00° β=90.00° γ=90.00°
(E)-4-(4-Hydroxy-3-methoxybenzylideneamino)-3- [1-(4-isobutylphenyl)ethyl]-1H-1,2,4-triazole-5(4H)-thione
C22H26N4O2S
Acta Crystallographica Section E (2010) 66, 1 o89-o90
a=9.8646(3)Å b=14.2026(5)Å c=16.6758(6)Å
α=69.048(2)° β=79.881(2)° γ=85.946(2)°
(<i>E</i>)-1-[(Diphenylamino)methyl]-4-(4-fluorobenzylideneamino)-3- [1-(4-isobutylphenyl)ethyl]-1<i>H</i>-1,2,4-triazole-5(4<i>H</i>)-thione
C34H34FN5S
Acta Crystallographica Section E (2010) 66, 1 o83-o84
a=10.8175(2)Å b=9.95790(10)Å c=27.8344(4)Å
α=90° β=105.1990(10)° γ=90°
2,2'-Dithiodianiline
C12H12N2S2
Acta Crystallographica Section E (2010) 66, 2 o292-o293
a=8.25310(10)Å b=13.0278(2)Å c=22.3655(4)Å
α=90° β=90° γ=90°
[3-(5-Nitro-2-furyl)-1-phenyl-1<i>H</i>-pyrazol-4-yl](phenyl)methanone
C20H13N3O4
Acta Crystallographica Section E (2010) 66, 5 o1229-o1230
a=11.2946(12)Å b=6.9755(8)Å c=22.7064(18)Å
α=90.00° β=115.015(4)° γ=90.00°
(<i>E</i>)-4-[(4-Fluorobenzylidene)amino]-3-[1-(4-isobutylphenyl)ethyl]-1- (morpholinomethyl)-1<i>H</i>-1,2,4-triazole-5(4<i>H</i>)-thione methanol hemisolvate
C26H32FN5OS,0.5(CH4O)
Acta Crystallographica Section E (2010) 66, 5 o1233-o1234
a=40.186(3)Å b=4.7840(3)Å c=30.073(2)Å
α=90.00° β=116.112(2)° γ=90.00°
3-(2,3-Dimethyl-5-oxo-1-phenyl-2,5-dihydro-1<i>H</i>-pyrazol-4-yl)sydnone
C13H12N4O3
Acta Crystallographica Section E (2010) 66, 6 o1251-o1252
a=10.6525(3)Å b=7.3014(3)Å c=15.6828(4)Å
α=90.00° β=93.9820(10)° γ=90.00°
4-[3-(1-Naphthyloxymethyl)-7<i>H</i>-1,2,4-triazolo[3,4- <i>b</i>][1,3,4]thiadiazin-6-yl]-3-<i>p</i>-tolylsydnone
C24H18N6O3S
Acta Crystallographica Section E (2010) 66, 6 o1394-o1395
a=21.6096(8)Å b=8.3622(3)Å c=11.9272(4)Å
α=90.00° β=94.6940(10)° γ=90.00°
4-(1<i>H</i>-Benzimidazol-2-ylmethyl)-2<i>H</i>-1,4-benzothiazin-3(4<i>H</i>)-one
C16H13N3OS
Acta Crystallographica Section E (2010) 66, 6 o1495
a=9.4498(8)Å b=17.0223(16)Å c=17.4454(16)Å
α=90.00° β=90.00° γ=90.00°
3-Phenyl-4-{3-[(<i>p</i>-tolyloxy)methyl]-7<i>H</i>-1,2,4- triazolo[3,4-<i>b</i>][1,3,4]thiadiazin-6-yl}sydnone
C20H16N6O3S
Acta Crystallographica Section E (2010) 66, 8 o2162-o2163
a=42.0781(12)Å b=8.2304(2)Å c=11.1488(3)Å
α=90.00° β=101.630(2)° γ=90.00°
4-[3-(Phenoxymethyl)-7<i>H</i>-1,2,4-\ triazolo[3,4-<i>b</i>][1,3,4]thiadiazin-6-yl]-3-(<i>p</i>-tolyl)sydnone
C20H16N6O3S
Acta Crystallographica Section E (2010) 66, 8 o2178-o2179
a=20.6555(7)Å b=8.1918(3)Å c=11.1979(4)Å
α=90.00° β=96.127(2)° γ=90.00°
4-[2,3-Dibromo-3-(4-bromophenyl)propanoyl]-2-phenyl-1,2,3-oxadiazol-2- ium-5-olate
C17H11Br3N2O3
Acta Crystallographica Section E (2010) 66, 11 o2818-o2819
a=17.6996(3)Å b=5.83220(10)Å c=18.2445(3)Å
α=90.00° β=105.9730(10)° γ=90.00°
2,3-Dibromo-1,3-bis(4-chlorophenyl)propan-1-one
C15H10Br2Cl2O
Acta Crystallographica Section E (2010) 66, 12 o3131
a=5.7599(3)Å b=17.1233(8)Å c=30.1983(13)Å
α=90.00° β=90.00° γ=90.00°
<i>N</i>-(4-Cyanophenyl)-2,6-difluorobenzamide
C14H8F2N2O
Acta Crystallographica Section E (2010) 66, 12 o3192
a=9.3377(11)Å b=5.0793(6)Å c=24.500(3)Å
α=90.00° β=100.202(3)° γ=90.00°
3-(<i>p</i>-Anisyl)sydnone
C9H8N2O3
Acta Crystallographica Section E (2010) 66, 12 o3252
a=7.0505(2)Å b=9.8220(3)Å c=12.0934(3)Å
α=90.00° β=90.00° γ=90.00°
4-({[4-Amino-5-(4-chloroanilinomethyl)-4<i>H</i>-1,2,4-triazol-3- yl]sulfanyl}acetyl)-3-(4-methoxyphenyl)-1,2,3-oxadiazol-3-ium-5-olate
C20H18ClN7O4S
Acta Crystallographica Section E (2010) 66, 12 o3178
a=20.109(3)Å b=5.8952(8)Å c=36.369(5)Å
α=90.00° β=96.076(3)° γ=90.00°
2,3-Dibromo-1-(4-methylphenyl)-3-(5-nitrofuran-2-yl)propan-1-one
C14H11Br2NO4
Acta Crystallographica Section E (2011) 67, 1 o79
a=8.7766(3)Å b=9.0386(3)Å c=10.4841(3)Å
α=87.601(2)° β=75.505(2)° γ=69.554(2)°
2,3-Dibromo-3-(5-nitro-2-furyl)-1-phenylpropan-1-one
C13H9Br2NO4
Acta Crystallographica Section E (2011) 67, 3 o546
a=8.6939(7)Å b=8.7834(8)Å c=10.4722(9)Å
α=89.334(2)° β=69.846(2)° γ=68.114(2)°
4-({[4-Amino-6-(p-bromobenzyl)-5-oxo-4,5-dihydro-1,2,4-triazin-3-yl] sulfanyl}acetyl)-3-phenylsydnone
C20H15BrN6O4S
Acta Crystallographica Section E (2011) 67, 4 o1004
a=6.3842(3)Å b=10.0832(5)Å c=17.1563(8)Å
α=104.8730(10)° β=93.5070(10)° γ=98.1890(10)°
2,3-Dibromo-3-phenyl-1-(3-phenylsydnon-4-yl)propan-1-one
C17H12Br2N2O3
Acta Crystallographica Section E (2011) 67, 4 o814
a=11.9109(3)Å b=17.5018(3)Å c=8.5365(2)Å
α=90.00° β=94.9600(10)° γ=90.00°
2,3-Dibromo-3-(4-bromophenyl)-1-[3-(4-methoxyphenyl)sydnon-4-yl]propan-1-one
C18H13Br3N2O4
Acta Crystallographica Section E (2011) 67, 4 o951
a=7.80240(10)Å b=24.0261(3)Å c=10.82110(10)Å
α=90.00° β=108.8480(10)° γ=90.00°
3-(<i>p</i>-Tolyl)-4-{3-[(phenylamino)methyl]-7<i>H</i>-[1,2,4]triazolo[3,4-\ <i>b</i>][1,3,4]thiadiazin-6-yl}sydnone
C20H17N7O2S
Acta Crystallographica Section E (2011) 67, 4 o1005-o1006
a=10.1210(4)Å b=10.5065(4)Å c=19.6370(6)Å
α=90° β=114.550(2)° γ=90°
3-Methyl-5-oxo-4-(2-phenylhydrazinylidene)-4,5-dihydro-1<i>H</i>-pyrazole-1- carbothioamide
C11H11N5OS
Acta Crystallographica Section E (2011) 67, 4 o928
a=7.73880(10)Å b=16.1103(3)Å c=11.3575(2)Å
α=90.00° β=121.0580(10)° γ=90.00°
4-[2-(2-Benzylidenehydrazinylidene)-3,6-dihydro-2<i>H</i>-1,3,4-thiadiazin- 5-yl]-3-(4-methoxyphenyl)sydnone
C19H16N6O3S
Acta Crystallographica Section E (2011) 67, 4 o902
a=14.9236(15)Å b=5.9331(7)Å c=21.425(2)Å
α=90.00° β=99.338(2)° γ=90.00°
4-{(<i>Z</i>)-2-[(<i>E</i>)-Benzylidenehydrazinylidene]-3,6-dihydro- 2<i>H</i>-1,3,4-thiadiazin-5-yl}-3-phenyl-1,2,3-oxadiazol-3-ium-5-olate
C18H14N6O2S
Acta Crystallographica Section E (2011) 67, 4 o977-o978
a=6.8752(2)Å b=10.1335(3)Å c=12.7374(4)Å
α=78.5780(10)° β=88.9840(10)° γ=85.8740(10)°
4-{2-[2-(4-Chlorobenzylidene)hydrazinylidene]-3,6-dihydro-2<i>H</i>- 1,3,4-thiadiazin-5-yl}-3-phenylsydnone
C18H13ClN6O2S
Acta Crystallographica Section E (2011) 67, 5 o1177-o1178
a=7.3180(3)Å b=10.1567(5)Å c=12.4721(6)Å
α=96.6860(10)° β=95.2850(10)° γ=95.2290(10)°
7-(4-Chlorobenzylidene)-3-[(4-chlorophenoxy)methyl]-6-(4-nitrothiophen-2-yl)- 7<i>H</i>-1,2,4-triazolo[3,4-<i>b</i>][1,3,4]thiadiazine
C22H13Cl2N5O3S2
Acta Crystallographica Section E (2011) 67, 5 o1266-o1267
a=8.5021(2)Å b=10.0379(2)Å c=14.3623(3)Å
α=94.4340(10)° β=97.9810(10)° γ=109.2420(10)°
4-{2-[2-(4-Chlorobenzylidene)hydrazinylidene]-3,6-dihydro-2<i>H</i>- 1,3,4-thiadiazin-5-yl}-3-(4-methoxyphenyl)sydnone
C19H15ClN6O3S
Acta Crystallographica Section E (2011) 67, 5 o1175-o1176
a=7.2322(2)Å b=22.7311(6)Å c=12.9299(3)Å
α=90.00° β=114.4260(10)° γ=90.00°
4-[(2,4-Difluorophenyl)hydrazinylidene]-3-methyl-5-oxo-4,5-dihydro- 1<i>H</i>-pyrazole-1-carbothioamide
C11H9F2N5OS
Acta Crystallographica Section E (2011) 67, 11 o3116
a=7.90030(10)Å b=8.24000(10)Å c=10.13780(10)Å
α=103.4090(10)° β=99.8640(10)° γ=99.3720(10)°
4-(2-{[4-Amino-6-(4-nitrobenzyl)-5-oxo-4,5-dihydro-1,2,4- triazin-3-yl]sulfanyl}acetyl)-3-phenylsydnone
C20H15N7O6S
Acta Crystallographica Section E (2011) 67, 5 o1196
a=6.40710(10)Å b=10.1629(2)Å c=17.1521(3)Å
α=106.3720(10)° β=92.4000(10)° γ=97.5510(10)°
Ethyl 2-[(2,4-difluorophenyl)hydrazinylidene]-3-oxobutanoate
C12H12F2N2O3
Acta Crystallographica Section E (2012) 68, 2 o422
a=21.814(4)Å b=9.0079(15)Å c=13.188(2)Å
α=90.00° β=90.00° γ=90.00°
3-(1-Benzofuran-2-yl)-1<i>H</i>-1,2,4-triazole-5(4<i>H</i>)-thione monohydrate
C10H7N3OS,H2O
Acta Crystallographica Section E (2012) 68, 7 o2067
a=7.14460(10)Å b=8.80750(10)Å c=17.3274(2)Å
α=90.00° β=111.9420(10)° γ=90.00°
<i>N</i>'-[(<i>E</i>)-4-Bromobenzylidene]-1-benzofuran-2-carbohydrazide monohydrate
C16H11BrN2O2,H2O
Acta Crystallographica Section E (2012) 68, 7 o2121
a=25.0594(4)Å b=4.67180(10)Å c=12.6166(2)Å
α=90.00° β=99.1750(10)° γ=90.00°
(2<i>E</i>)-2-[(3-Methyl-5-phenoxy-1-phenyl-1<i>H</i>-pyrazol-4- yl)methylidene]hydrazinecarbothioamide
C18H17N5OS
Acta Crystallographica Section E (2012) 68, 7 o2146-o2147
a=8.82800(10)Å b=10.8519(2)Å c=17.7353(2)Å
α=90.00° β=94.3790(10)° γ=90.00°
<i>N</i>'-[(<i>E</i>)-3-Chloro-2-fluorobenzylidene]-6- methylnicotinohydrazide monohydrate
C14H11ClFN3O,H2O
Acta Crystallographica Section E (2012) 68, 7 o2122
a=9.7898(12)Å b=6.4440(8)Å c=23.121(3)Å
α=90.00° β=106.614(5)° γ=90.00°
(<i>E</i>)-<i>N</i>'-(4-Chlorobenzylidene)-1-benzofuran-2-carbohydrazide monohydrate
C16H11ClN2O2,H2O
Acta Crystallographica Section E (2012) 68, 7 o2163
a=24.6121(15)Å b=4.6625(3)Å c=12.6570(8)Å
α=90.00° β=99.2940(10)° γ=90.00°
3-Methyl-4-[2-(4-nitrophenyl)hydrazin-1-ylidene]-5-oxo-4,5-dihydro-1<i>H</i>- pyrazole-1-carbothioamide
C11H10N6O3S
Acta Crystallographica Section E (2012) 68, 7 o2162
a=11.5331(4)Å b=17.2540(6)Å c=13.6025(5)Å
α=90.00° β=105.840(2)° γ=90.00°
<i>N</i>'-[1-(4-Chlorophenyl)ethylidene]-5-methyl-1-(4-nitrophenyl)-1<i>H</i>- 1,2,3-triazole-4-carbohydrazide
C18H15ClN6O3
Acta Crystallographica Section E (2012) 68, 7 o2164
a=8.66030(10)Å b=10.28440(10)Å c=10.40330(10)Å
α=83.8160(10)° β=81.4020(10)° γ=76.3730(10)°
4-Bromoacetyl-3-phenylsydnone
C10H7BrN2O3
Acta Crystallographica Section E (2012) 68, 7 o2103
a=7.2030(2)Å b=5.87780(10)Å c=25.1133(5)Å
α=90.00° β=91.104(2)° γ=90.00°
4-Acetyl-3-(<i>p</i>-anisyl)sydnone
C11H10N2O4
Acta Crystallographica Section E (2011) 67, 6 o1489
a=9.6338(8)Å b=10.0679(7)Å c=22.4108(18)Å
α=86.938(3)° β=78.049(2)° γ=89.891(2)°
Ethyl 5-methyl-1-(4-nitrophenyl)-1<i>H</i>-1,2,3-triazole-4-carboxylate
C12H12N4O4
Acta Crystallographica Section E (2011) 67, 9 o2416
a=13.5309(3)Å b=7.3014(2)Å c=12.6058(3)Å
α=90.00° β=99.5740(10)° γ=90.00°
3-(4-Nitrophenyl)-1<i>H</i>-1,2,4-triazole-5(4<i>H</i>)-thione
C8H6N4O2S
Acta Crystallographica Section E (2011) 67, 9 o2413
a=7.82210(10)Å b=8.21090(10)Å c=14.6757(3)Å
α=90.00° β=101.3020(10)° γ=90.00°
2-[5-Methyl-2-(propan-2-yl)phenoxy]-<i>N</i>'- {2-[5-methyl-2-(propan-2-yl)phenoxy]acetyl}acetohydrazide
C24H32N2O4
Acta Crystallographica Section E (2011) 67, 9 o2414
a=23.6018(8)Å b=11.2077(4)Å c=8.6653(3)Å
α=90.00° β=90.00° γ=90.00°
4-[2-(4-Chlorophenyl)hydrazinylidene]-3-methyl-1<i>H</i>- pyrazol-5(4<i>H</i>)-one
C10H9ClN4O
Acta Crystallographica Section E (2011) 67, 10 o2670
a=15.8496(5)Å b=3.81840(10)Å c=20.3794(6)Å
α=90.00° β=123.575(2)° γ=90.00°
Ethyl 2-[2-(3-methoxyphenyl)hydrazinylidene]-3-oxobutanoate
C13H16N2O4
Acta Crystallographica Section E (2011) 67, 10 o2809
a=5.7796(4)Å b=7.4691(5)Å c=16.9842(11)Å
α=77.956(2)° β=89.394(2)° γ=72.547(2)°
3-Methyl-5-phenoxy-1-phenyl-1<i>H</i>-pyrazole-4-carbaldehyde
C17H14N2O2
Acta Crystallographica Section E (2011) 67, 10 o2646
a=8.62070(10)Å b=7.16950(10)Å c=22.9228(3)Å
α=90.00° β=99.1680(10)° γ=90.00°
Ethyl 2-[2-(2-methoxyphenyl)hydrazinylidene]-3-oxobutanoate
C13H16N2O4
Acta Crystallographica Section E (2011) 67, 10 o2571
a=10.1885(4)Å b=11.4967(4)Å c=13.2492(5)Å
α=90.00° β=120.003(3)° γ=90.00°
4-[2-(4-Bromophenyl)hydrazinylidene]-3-methyl-5-oxo-4,5-dihydro- 1<i>H</i>-pyrazole-1-carbothioamide
C11H10BrN5OS
Acta Crystallographica Section E (2011) 67, 10 o2570
a=25.6080(18)Å b=11.6686(8)Å c=9.0823(6)Å
α=90.00° β=98.907(2)° γ=90.00°
4-[2-(2-Methoxyphenyl)hydrazinylidene]-3-methyl-5-oxo-4,5-dihydro-1<i>H</i>- pyrazole-1-carbothioamide
C12H13N5O2S
Acta Crystallographica Section E (2011) 67, 10 o2711
a=14.3207(13)Å b=5.2003(5)Å c=19.5919(18)Å
α=90.00° β=108.369(2)° γ=90.00°
4-[2-(4-Chlorophenyl)hydrazinylidene]-3-methyl-5-oxo-4,5-dihydro-1<i>H</i>- pyrazole-1-carbothioamide
C11H10ClN5OS
Acta Crystallographica Section E (2011) 67, 10 o2740
a=25.0899(17)Å b=11.6075(9)Å c=9.0806(6)Å
α=90.00° β=99.5160(10)° γ=90.00°
(<i>E</i>)-4-{[(3-Propyl-5-sulfanylidene-4,5-dihydro-1<i>H</i>-1,2,4-triazol- 4-yl)imino]methyl}-3-(<i>p</i>-tolyl)-1,2,3-oxadiazol-3-ium-5-olate
C15H16N6O2S
Acta Crystallographica Section E (2011) 67, 10 o2668-o2669
a=13.4220(11)Å b=6.2411(5)Å c=21.1374(16)Å
α=90.00° β=104.575(2)° γ=90.00°
1-[2-(4-Chlorophenyl)-5-phenyl-2,3-dihydro-1,3,4-oxadiazol-3-yl]ethanone
C16H14ClN3O2
Acta Crystallographica Section E (2012) 68, 6 o1901
a=5.8623(2)Å b=10.9912(5)Å c=12.2815(5)Å
α=68.2140(10)° β=84.7070(10)° γ=87.6230(10)°
<i>N</i>'-(3,4-Dichlorobenzylidene)-5-methyl-1-(4-nitrophenyl)-1<i>H</i>- 1,2,3-triazole-4-carbohydrazide
C17H12Cl2N6O3
Acta Crystallographica Section E (2012) 68, 6 o1902
a=6.6309(3)Å b=22.7059(10)Å c=13.3019(5)Å
α=90.00° β=119.559(2)° γ=90.00°
<i>N</i>'-[(<i>E</i>)-1-(4-Bromophenyl)ethylidene]-2-(2-methyl-4-nitro- 1<i>H</i>-imidazol-1-yl)acetohydrazide
C14H14BrN5O3
Acta Crystallographica Section E (2012) 68, 7 o2192
a=8.41760(10)Å b=10.65410(10)Å c=17.4933(2)Å
α=90.00° β=90.1000(10)° γ=90.00°
2,3-Dibromo-3-(4-chlorophenyl)-1-(4-nitrothiophen-2-yl)propan-1-one
C13H8Br2ClNO3S
Acta Crystallographica Section E (2012) 68, 9 o2681
a=28.5425(17)Å b=9.5470(5)Å c=11.4047(7)Å
α=90.00° β=103.224(2)° γ=90.00°
(<i>E</i>)-<i>N</i>'-(4-Methoxybenzylidene)-2-(2-methyl-4-nitro-1<i>H</i>- imidazol-1-yl)acetohydrazide
C14H15N5O4
Acta Crystallographica Section E (2012) 68, 10 o2988-o2989
a=4.33660(10)Å b=12.9773(3)Å c=13.2138(3)Å
α=84.919(2)° β=87.353(2)° γ=84.6110(10)°
(2<i>E</i>)-2-{[3-Methyl-5-(2-naphthyloxy)-1-phenyl-1<i>H</i>- pyrazol-4-yl]methylidene}hydrazinecarbothioamide monohydrate
C22H19N5OS,H2O
Acta Crystallographica Section E (2012) 68, 10 o3055-o3056
a=7.9384(2)Å b=11.1512(2)Å c=13.0325(3)Å
α=113.4810(10)° β=90.9420(10)° γ=107.3590(10)°
2-Amino-6-methyl-5-{5-[(naphthalen-2-yloxy)methyl]-1,3,4-oxadiazol-2-ylsulfanyl}-4-(3-nitrophenyl)pyridine-3-carbonitrile
C26H18N6O4S
Acta Crystallographica Section E (2013) 69, 4 o491-o492
a=9.6132(9)Å b=9.8928(10)Å c=25.724(2)Å
α=83.215(2)° β=84.102(2)° γ=72.564(2)°
Dimethyl 2-[2-(2,4,6-trichlorophenyl)hydrazin-1-ylidene]butanedioate
C12H11Cl3N2O4
Acta Crystallographica Section E (2014) 70, 1 o13
a=7.0182(5)Å b=16.0165(12)Å c=26.7488(15)Å
α=90.00° β=90.00° γ=90.00°
<i>N</i>'-Benzylidene-2-chloro-<i>N</i>-(4-chlorophenyl)acetohydrazide
C15H12Cl2N2O
Acta Crystallographica Section E (2014) 70, 1 o31
a=5.8548(5)Å b=8.8892(7)Å c=28.273(2)Å
α=90° β=93.574(4)° γ=90°
5-(5'-Fluoro-2'-methoxybiphenyl-3-yl)-1,3,4-oxadiazol-2-amine
C15H12FN3O2
Acta Crystallographica Section E (2013) 69, 12 o1788
a=12.9105(9)Å b=6.1738(4)Å c=16.9255(11)Å
α=90.00° β=90.341(7)° γ=90.00°
3-[5-(4-Chlorophenoxy)-3-methyl-1-phenyl-1<i>H</i>-pyrazol-4-yl]-1-[4-(prop-2-yn-1-yloxy)phenyl]prop-2-en-1-one
C28H21ClN2O3
Acta Crystallographica Section E (2020) 76, 5 683-691
a=8.9959(14)Å b=9.7380(15)Å c=13.637(2)Å
α=95.901(4)° β=94.122(4)° γ=95.959(4)°
1-(4-Azidophenyl)-3-[3-methyl-5-(naphthalen-2-yloxy)-1-phenyl-1<i>H</i>-pyrazol-4-yl]prop-2-en-1-on
C29H21N5O2
Acta Crystallographica Section E (2020) 76, 5 683-691
a=9.8460(8)Å b=22.4303(18)Å c=11.0490(9)Å
α=90° β=104.157(2)° γ=90°
1-(4-Methoxyphenyl)-1<i>H</i>-pyrazole-3,4-dicarbohydrazide
C12H14N6O3
Acta Crystallographica Section E (2018) 74, 12 1783-1789
a=7.6030(6)Å b=22.6605(19)Å c=7.6751(7)Å
α=90° β=102.284(3)° γ=90°